Received Mar 18, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TYP | TYPHOID LIVE ORAL TY21A (VIVOTIF) | BERNA BIOTECH, LTD. | 2 | Unknown | PO / MO |
The patient took the second dose of Vivotif on the day two instead of the day three; Case reference number US-BN-2025-000920 is a spontaneous case initially received from pharmacist via Communication (reference number: USBAV25-1064) on 08-May-2025 and concern a patient of unspecified age and gender. The patient's medical history and concomitant medication details were not provided. On unspecified date, reported as day one, the patient took first dose of Vivotif (batch number: unknown) at an unknown dose, orally for unknown indication. On unspecified date, reported as day two, instead of on the day three, the patient took second dose of Vivotif (batch number: unknown) at an unknown dose, orally (explicitly coded as 'inappropriate schedule of vaccine administered'). At the time of initial report, it was unknown if the patient experienced any adverse events due Vivotif. No further information was provided.; Reporter's Comments: A patient of unspecified age and gender took the second dose of Vivotif reported as on the day two, instead of on the day three, which is considered as inappropriate schedule of vaccine administered. It was unknown if the patient experienced any adverse events due Vivotif. Inappropriate schedule of vaccine administered is considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Inappropriate schedule of vaccine administered is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: A patient of unspecified age and gender took the second dose of Vivotif reported as on the day two, instead of on the day three, which is considered as inappropriate schedule of vaccine administered. It was unknown if the patient experienced any adverse events due Vivotif. Inappropriate schedule of vaccine administered is considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Inappropriate schedule of vaccine administered is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.
Comments: None